BioSpace News Archive

Cianna Medical, powered by Merit Medical, has been named a “Top 10 Oncology Solution Provider” by Healthcare Tech Outlook, an innovation-focused healthcare publication for health system decision-makers.

Heska Corporation (NASDAQ: HSKA - News; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and specialty healthcare products, today reported financial results for its second quarter ended June 30, 2019.

Thermo Scientific Medical Device portfolio provides an extensive range of chromatography and mass spectrometry instruments for performing laboratory developed tests

AACC 2019 – New blood tests may help healthcare providers identify if patients are sensitized to up to 11 different molecular allergen component proteins found in dogs, cats, or horses.

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA

Bayer has awarded BioSTL, a St. Louis-based non-profit which advances and promotes the region’s growing bioscience, innovation and technology community, a $1.5 million grant to support its new headquarters.

Aevi Genomic Medicine, Inc. announced that Michael F. Cola, President and Chief Executive Officer, will present at the 2019 Wedbush PacGrow Healthcare Conference on Tuesday, August 13, 2019 at 1:20 p.m. EDT at the Parker New York Hotel in New York, NY.

Gilead Sciences Canada, Inc. (Gilead Canada) today announced that effective July 31, the Ontario Drug Benefit Program will provide eligible patients with access to Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg) tablets, a once-daily single tablet and complete regimen for the treatment of HIV-1 infection in adults.

Rodin Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for synaptopathies, announced the appointment of veteran investment professional Ajim Tamboli as chief financial officer.

Emalex Biosciences Inc., a biopharmaceutical company developing innovative therapies for patients with neurological and psychiatric conditions, today announced the appointment of Atul Mahableshwarkar, MD, as Senior Vice President of Drug Development